acorda.com · 1,094
Acorda Therapeutics is a renowned biotechnology company dedicated to developing and commercializing innovative therapies for neurological disorders such as Parkinson's disease, migraine, and multiple sclerosis. With a focus on research and development, Acorda is committed to providing groundbreaking treatments that improve the lives of patients around the world. The company's flagship products, including AMPYRA® (dalfampridine) and INBRIJA® (levodopa inhalation powder), are designed to address the specific needs of individuals living with these conditions. In addition to its cutting-edge products, Acorda offers a range of resources and support services for patients, caregivers, and healthcare professionals. Through a combination of scientific expertise, strategic partnerships, and a dedication to excellence, Acorda Therapeutics is leading the way in the field of neurology. Join us as we continue to drive innovation and make a difference in the lives of those affected by neurological disorders.
acorda.com · years statistic
1999
| 1 | 0 |
| 2 | 0 |
| 3 | 0 |
| 4 | 0 |
| 5 | 0 |
| 6 | 0 |
| 7 | 0 |
| 8 | 0 |
| 9 | 0 |
| 10 | 1 |
| 11 | 2 |
| 12 | 0 |
2000
| 1 | 0 |
| 2 | 1 |
| 3 | 0 |
| 4 | 0 |
| 5 | 0 |
| 6 | 2 |
| 7 | 0 |
| 8 | 1 |
| 9 | 0 |
| 10 | 3 |
| 11 | 0 |
| 12 | 1 |
2001
| 1 | 2 |
| 2 | 1 |
| 3 | 1 |
| 4 | 2 |
| 5 | 1 |
| 6 | 0 |
| 7 | 1 |
| 8 | 0 |
| 9 | 1 |
| 10 | 0 |
| 11 | 0 |
| 12 | 0 |
2002
| 1 | 1 |
| 2 | 0 |
| 3 | 1 |
| 4 | 0 |
| 5 | 2 |
| 6 | 0 |
| 7 | 3 |
| 8 | 2 |
| 9 | 3 |
| 10 | 0 |
| 11 | 2 |
| 12 | 0 |
2003
| 1 | 1 |
| 2 | 3 |
| 3 | 3 |
| 4 | 2 |
| 5 | 2 |
| 6 | 1 |
| 7 | 3 |
| 8 | 0 |
| 9 | 0 |
| 10 | 4 |
| 11 | 1 |
| 12 | 3 |
2004
| 1 | 1 |
| 2 | 1 |
| 3 | 0 |
| 4 | 3 |
| 5 | 2 |
| 6 | 4 |
| 7 | 2 |
| 8 | 3 |
| 9 | 3 |
| 10 | 0 |
| 11 | 2 |
| 12 | 1 |
2005
| 1 | 1 |
| 2 | 4 |
| 3 | 1 |
| 4 | 1 |
| 5 | 2 |
| 6 | 1 |
| 7 | 1 |
| 8 | 0 |
| 9 | 1 |
| 10 | 0 |
| 11 | 1 |
| 12 | 5 |
2006
| 1 | 3 |
| 2 | 5 |
| 3 | 4 |
| 4 | 5 |
| 5 | 0 |
| 6 | 4 |
| 7 | 4 |
| 8 | 4 |
| 9 | 0 |
| 10 | 2 |
| 11 | 3 |
| 12 | 1 |
2007
| 1 | 5 |
| 2 | 3 |
| 3 | 2 |
| 4 | 2 |
| 5 | 1 |
| 6 | 3 |
| 7 | 0 |
| 8 | 6 |
| 9 | 0 |
| 10 | 5 |
| 11 | 0 |
| 12 | 0 |
2008
| 1 | 1 |
| 2 | 1 |
| 3 | 1 |
| 4 | 0 |
| 5 | 2 |
| 6 | 0 |
| 7 | 0 |
| 8 | 0 |
| 9 | 0 |
| 10 | 2 |
| 11 | 0 |
| 12 | 2 |
2009
| 1 | 1 |
| 2 | 1 |
| 3 | 1 |
| 4 | 0 |
| 5 | 0 |
| 6 | 0 |
| 7 | 0 |
| 8 | 0 |
| 9 | 0 |
| 10 | 0 |
| 11 | 0 |
| 12 | 0 |
2010
| 1 | 0 |
| 2 | 0 |
| 3 | 2 |
| 4 | 2 |
| 5 | 1 |
| 6 | 0 |
| 7 | 1 |
| 8 | 1 |
| 9 | 1 |
| 10 | 2 |
| 11 | 1 |
| 12 | 2 |
2011
| 1 | 1 |
| 2 | 5 |
| 3 | 1 |
| 4 | 0 |
| 5 | 1 |
| 6 | 0 |
| 7 | 3 |
| 8 | 2 |
| 9 | 2 |
| 10 | 2 |
| 11 | 1 |
| 12 | 1 |
2012
| 1 | 2 |
| 2 | 7 |
| 3 | 4 |
| 4 | 1 |
| 5 | 4 |
| 6 | 2 |
| 7 | 2 |
| 8 | 0 |
| 9 | 0 |
| 10 | 1 |
| 11 | 1 |
| 12 | 0 |
2013
| 1 | 2 |
| 2 | 0 |
| 3 | 1 |
| 4 | 1 |
| 5 | 1 |
| 6 | 4 |
| 7 | 9 |
| 8 | 0 |
| 9 | 2 |
| 10 | 0 |
| 11 | 1 |
| 12 | 0 |
2014
| 1 | 11 |
| 2 | 3 |
| 3 | 1 |
| 4 | 1 |
| 5 | 1 |
| 6 | 0 |
| 7 | 1 |
| 8 | 2 |
| 9 | 2 |
| 10 | 4 |
| 11 | 2 |
| 12 | 19 |
2015
| 1 | 1 |
| 2 | 6 |
| 3 | 7 |
| 4 | 2 |
| 5 | 1 |
| 6 | 0 |
| 7 | 2 |
| 8 | 1 |
| 9 | 2 |
| 10 | 2 |
| 11 | 1 |
| 12 | 2 |
2016
| 1 | 4 |
| 2 | 2 |
| 3 | 7 |
| 4 | 3 |
| 5 | 2 |
| 6 | 2 |
| 7 | 5 |
| 8 | 2 |
| 9 | 2 |
| 10 | 5 |
| 11 | 2 |
| 12 | 1 |
2017
| 1 | 0 |
| 2 | 1 |
| 3 | 2 |
| 4 | 1 |
| 5 | 2 |
| 6 | 3 |
| 7 | 5 |
| 8 | 3 |
| 9 | 3 |
| 10 | 3 |
| 11 | 4 |
| 12 | 2 |
2018
| 1 | 3 |
| 2 | 4 |
| 3 | 3 |
| 4 | 3 |
| 5 | 3 |
| 6 | 2 |
| 7 | 3 |
| 8 | 5 |
| 9 | 1 |
| 10 | 4 |
| 11 | 1 |
| 12 | 1 |
2019
| 1 | 1 |
| 2 | 1 |
| 3 | 0 |
| 4 | 1 |
| 5 | 5 |
| 6 | 4 |
| 7 | 2 |
| 8 | 5 |
| 9 | 6 |
| 10 | 4 |
| 11 | 6 |
| 12 | 10 |
2020
| 1 | 1 |
| 2 | 13 |
| 3 | 2 |
| 4 | 31 |
| 5 | 26 |
| 6 | 17 |
| 7 | 26 |
| 8 | 36 |
| 9 | 28 |
| 10 | 27 |
| 11 | 28 |
| 12 | 12 |
2021
| 1 | 12 |
| 2 | 20 |
| 3 | 33 |
| 4 | 12 |
| 5 | 20 |
| 6 | 13 |
| 7 | 4 |
| 8 | 10 |
| 9 | 8 |
| 10 | 10 |
| 11 | 11 |
| 12 | 20 |
2022
| 1 | 14 |
| 2 | 3 |
| 3 | 20 |
| 4 | 7 |
| 5 | 7 |
| 6 | 11 |
| 7 | 16 |
| 8 | 11 |
| 9 | 10 |
| 10 | 5 |
| 11 | 4 |
| 12 | 7 |
2023
| 1 | 2 |
| 2 | 13 |
| 3 | 13 |
| 4 | 6 |
| 5 | 7 |
| 6 | 11 |
| 7 | 3 |
| 8 | 12 |
| 9 | 5 |
| 10 | 4 |
| 11 | 4 |
| 12 | 2 |
2024
| 1 | 6 |
| 2 | 1 |
| 3 | 1 |
| 4 | 3 |
| 5 | 0 |
| 6 | 0 |
| 7 | 0 |
| 8 | 0 |
| 9 | 0 |
| 10 | 0 |
| 11 | 0 |
| 12 | 0 |
acorda.com · links
Healthcare
United States
English
rnioi.ru
475
National Medical Research Center of Oncology of the Ministry of Health of Russia
